Search Results - "Hewkin, Ann C"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Dogma disputed : Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? by MESSERLI, Franz H, MANCIA, Giuseppe, CONTI, C. Richard, HEWKIN, Ann C, KUPFER, Stuart, CHAMPION, Annette, KOLLOCH, Rainer, BENETOS, Athanase, PEPINE, Carl J

    Published in Annals of internal medicine (20-06-2006)
    “…Because coronary perfusion occurs mainly during diastole, patients with coronary artery disease (CAD) could be at increased risk for coronary events if…”
    Get full text
    Journal Article
  2. 2

    Effects of sibutramine treatment in obese adolescents: a randomized trial by Berkowitz, Robert I, Fujioka, Ken, Daniels, Stephen R, Hoppin, Alison G, Owen, Stanford, Perry, Arlette C, Sothern, Melinda S, Renz, Cheryl L, Pirner, Mark A, Walch, Julia K, Jasinsky, Olga, Hewkin, Ann C, Blakesley, Vicky A

    Published in Annals of internal medicine (18-07-2006)
    “…Increased prevalence of adolescent obesity requires effective treatment options beyond behavior therapy. To see whether sibutramine reduced weight more than…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients by Early, James L., Apovian, Caroline M., Aronne, Louis J., Fernstrom, Madelyn H., Frank, Arthur, Greenway, Frank L., Heber, David, Kushner, Robert F., Cwik, Kristine M., Walch, Julia K., Hewkin, Ann C., Blakesley, Vicky

    Published in Obesity (Silver Spring, Md.) (01-06-2007)
    “…Objective: Our objective was to assess the efficacy and safety of sibutramine with a low‐calorie diet (LCD) and commercial meal‐replacement product in…”
    Get full text
    Journal Article
  6. 6

    A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease Patients by Elliott, William J., Hewkin, Ann C., Kupfer, Stuart, Cooper‐DeHoff, Rhonda, Pepine, Carl J.

    “…To understand the effects of single‐ and multiple‐drug combinations for hypertension on the risk of adverse clinical outcomes, the authors analyzed data from…”
    Get full text
    Journal Article
  7. 7

    P-229: Association of BP control and frequency of mortality and CV morbidity in hypertensive patients with CAD: the international verapamil SR-trandolapril study by Mancia, Giuseppe, Cooper-DeHoff, Rhonda M., Hewkin, Ann C., Kupfer, Stuart R., Pepine, Carl J.

    Published in American journal of hypertension (01-05-2004)
    “…Hypertension is generally considered a risk factor for CV disease; however, limited data are available on the impact of BP reduction on CV outcomes in the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    P-423: Incidence of MI is equivalent with verapamil SR-based and atenolol-based strategies in patients with hypertension and CAD: The international verapamil SR-trandolapril study by Cohen, Jerome D., Kowey, Peter R., Sleight, Peter, Hewkin, Ann C., Handberg, Eileen M., Kupfer, Stuart R., Pepine, Carl J.

    Published in American journal of hypertension (01-05-2004)
    “…β-blockers are usually recommended for hypertension treatment in patients with CAD; however, this recommendation is based on trials in which BP control was not…”
    Get full text
    Journal Article
  10. 10

    Characteristics of contemporary patients with hypertension and coronary artery disease by Cooper‐DeHoff, Rhonda M., Handberg, Eileen M., Cohen, Jerome, Kowey, Peter, Messerli, Franz H., Mancia, Giuseppe, Cangiano, Jose L., Gaxiola, Efrain, Garcia‐Barreto, David, Hewkin, Ann C., Pepine, Carl J.

    Published in Clinical cardiology (Mahwah, N.J.) (01-10-2004)
    “…Background: Despite a high prevalence of hypertension in the population with CAD, there are limited data describing the clinical characteristics and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14